Screener
Cullinan Therapeutics, Inc. CGEM Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $1.12B.
The source filing: Cullinan Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336717
FAQ
- What is Cullinan Therapeutics, Inc.'s market capitalization?
- Cullinan Therapeutics, Inc. (CGEM) reported market capitalization of $1.12B in Q2 2026.
- How has Cullinan Therapeutics, Inc.'s market capitalization changed year-over-year?
- Cullinan Therapeutics, Inc.'s market capitalization increased by 141.9% year-over-year, from $462.67M to $1.12B.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s market capitalization?
- Over 4 years (2021 to 2025), Cullinan Therapeutics, Inc.'s market capitalization has grown at a -2.8% compound annual growth rate (CAGR), from $685.58M to $611.44M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Cullinan Therapeutics, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude